The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-[(E)-3-Hydroxy-2-methyl-3-(3,4,5-trimethoxy-phenyl)-propenyl]-2-methoxy-phenol ID: ALA191957
PubChem CID: 10309096
Max Phase: Preclinical
Molecular Formula: C20H24O6
Molecular Weight: 360.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(/C=C(\C)C(O)c2cc(OC)c(OC)c(OC)c2)cc1O
Standard InChI: InChI=1S/C20H24O6/c1-12(8-13-6-7-16(23-2)15(21)9-13)19(22)14-10-17(24-3)20(26-5)18(11-14)25-4/h6-11,19,21-22H,1-5H3/b12-8+
Standard InChI Key: VTPCPBBVWDRRAV-XYOKQWHBSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
5.6194 -18.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6182 -19.6315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3331 -20.0444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0495 -19.6310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0466 -18.8005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3313 -18.3914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7596 -18.3853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4756 -18.7951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7564 -17.5603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4787 -19.6201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1885 -18.3799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9045 -18.7897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9045 -19.6136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6197 -20.0233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3336 -19.6081 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3278 -18.7788 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6120 -18.3728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9048 -18.3918 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9046 -17.5668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9034 -20.0434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1893 -19.6304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3329 -20.8694 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6183 -21.2817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0392 -18.3611 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0501 -20.0169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.0543 -20.8419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 12 1 0
1 18 1 0
7 9 1 0
18 19 1 0
4 5 1 0
2 20 1 0
8 10 1 0
20 21 1 0
2 3 1 0
3 22 1 0
8 11 2 0
22 23 1 0
5 6 2 0
16 24 1 0
11 12 1 0
15 25 1 0
6 1 1 0
25 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.41Molecular Weight (Monoisotopic): 360.1573AlogP: 3.56#Rotatable Bonds: 7Polar Surface Area: 77.38Molecular Species: NEUTRALHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.84CX Basic pKa: ┄CX LogP: 2.91CX LogD: 2.91Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.79Np Likeness Score: 0.66
References 1. Ducki S, Mackenzie G, Lawrence NJ, Snyder JP.. (2005) Quantitative structure-activity relationship (5D-QSAR) study of combretastatin-like analogues as inhibitors of tubulin assembly., 48 (2): [PMID:15658859 ] [10.1021/jm049444m ] 2. Ducki S, Rennison D, Woo M, Kendall A, Chabert JF, McGown AT, Lawrence NJ.. (2009) Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity., 17 (22): [PMID:19837593 ] [10.1016/j.bmc.2009.09.039 ]